Medicare Enrolled

Dr. Pooja Banerjee, MD

Rheumatology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
8220 WALNUT HILL LN STE 414, Dallas, TX 75231
4699160677
In practice since 2006 (20 years)
NPI: 1538138011 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Banerjee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banerjee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Banerjee

Dr. Pooja Banerjee is a rheumatology in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Banerjee performed 104,660 Medicare services across 361 unique beneficiaries.

Between the years covered by Open Payments, Dr. Banerjee received a total of $16,350 from 30 pharmaceutical and/or device companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Banerjee is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 15% volume in TX$ $16,350 industry payments

Medicare Practice Summary

Medicare Utilization ↗
104,660
Medicare services
Top 15% in TX for rheumatology
361
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,233 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)74,400$4$15
Golimumab infusion (Simponi Aria)24,241$11$39
Abatacept infusion (Orencia)4,875$34$126
Office visit, established patient (30-39 min)499$91$270
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle372$55$189
Administration of chemotherapy into vein, 1 hour or less231$96$345
New patient office visit (45-59 min)25$128$415
New patient office visit, complex (60-74 min)17$174$521
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.8% high complexity
71.7% medium
0.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,350
Total received (2018-2024)
Avg $2,336/year across 7 years
Top 22% in TX for rheumatology
30
Companies
482
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,409 (57.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,335 (38.7%)
Scientific / Research
Research funding and grants
$382 (2.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$224 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,206
2023
$1,340
2022
$2,304
2021
$894
2020
$969
2019
$7,761
2018
$876

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$7,408
Janssen Biotech, Inc.
$3,510
PFIZER INC.
$789
Amgen Inc.
$585
ABBVIE INC.
$521
AstraZeneca Pharmaceuticals LP
$425
E.R. Squibb & Sons, L.L.C.
$414
Genentech USA, Inc.
$389
AbbVie Inc.
$382
Novartis Pharmaceuticals Corporation
$369
GlaxoSmithKline, LLC.
$258
Lilly USA, LLC
$192
Janssen Scientific Affairs, LLC
$142
Horizon Therapeutics plc
$135
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
ANI Pharmaceuticals, Inc.
$100
Celgene Corporation
$92
AbbVie, Inc.
$90
Alexion Pharmaceuticals, Inc.
$87
Progentec Diagnostics, Inc.
$76
Aurinia Pharma U.S., Inc.
$63
Fresenius Kabi USA, LLC
$35
Merck Sharp & Dohme Corporation
$31
Organon LLC
$29
Horizon Pharma plc
$26
GENZYME CORPORATION
$21
Sobi, Inc
$18
MEDEXUS PHARMA, INC.
$14
MEDAC PHARMA, INC.
$12
Organon Llc
$12
Top 3 companies account for 71.6% of total payments
Associated products mentioned in payments ›
AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · HADLIMA · HUMIRA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · NEXPLANON · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $16 per 100 Medicare services performed
Looking for a rheumatology in Dallas?
Compare rheumatologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
99
Per 100K population
3.8
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Banerjee is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and consulting-driven industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Banerjee experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Banerjee performed 74,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banerjee receive payments from pharmaceutical companies?
Yes. Dr. Banerjee received a total of $16,350 from 30 companies across 482 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banerjee's costs compare to other rheumatologys in Dallas?
Dr. Banerjee's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banerjee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →